Security Snapshot

SIEMENS HEALTHINEERS AG UNSPONSORED ADR - ADR (SMMNY) Institutional Ownership

CUSIP: 82622J104

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

10

Shares (Excl. Options)

108,643

Price

$26.23

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / ADR
Symbol
SMMNY
Price per share
$21.05
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
108,643
Total reported value
$2,850,069
% of total 13F portfolios
0%
Share change
-47,836
Value change
-$1,254,368
Number of holders
10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SMMNY - SIEMENS HEALTHINEERS AG UNSPONSORED ADR - ADR is tracked under CUSIP 82622J104.
  • 10 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 10 to 2 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,850,069 to $101,990.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 10 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 82622J104?
CUSIP 82622J104 identifies SMMNY - SIEMENS HEALTHINEERS AG UNSPONSORED ADR - ADR in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 10 institutional investors reported holding 108,643 shares of SIEMENS HEALTHINEERS AG UNSPONSORED ADR - ADR (SMMNY).

Institutional Holders of SIEMENS HEALTHINEERS AG UNSPONSORED ADR - ADR (SMMNY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,818 $101,990 +$50,517 $21.05 2
2025 Q4 108,643 $2,850,069 -$1,254,368 $26.23 10
2025 Q3 156,448 $4,234,004 +$648,405 $27.06 8
2025 Q2 132,568 $3,675,999 -$3,041,824 $27.74 9
2025 Q1 242,203 $6,503,407 +$564,700 $26.85 7
2024 Q4 221,308 $5,822,557 -$495,286 $26.31 6
2024 Q3 240,124 $7,196,227 -$358,935 $29.97 7
2024 Q2 252,102 $7,228,247 -$178,838 $28.67 8
2024 Q1 258,336 $7,897,325 -$7,857,179 $30.57 8
2023 Q4 266,899 $7,772,040 -$9,085,679 $29.13 7
2023 Q3 347,449 $8,800,410 -$7,923,364 $25.33 10
2023 Q2 352,675 $9,968,596 -$6,626,406 $28.27 9
2023 Q1 303,050 $8,714,258 -$6,671,187 $28.79 6
2022 Q4 294,443 $7,340,596 -$6,849,842 $24.93 4
2022 Q3 303,912 $6,542,000 -$7,570,693 $21.52 3
2022 Q2 310,397 $7,863,095 -$9,428,390 $25.35 5
2022 Q1 314,384 $9,749,000 -$11,070,249 $31.09 5
2021 Q4 309,985 $11,827,000 -$8,463,972 $37.83 6
2021 Q3 293,249 $9,534,000 -$4,741,935 $32.54 4
2021 Q2 233,978 $7,177,073 -$27,684,525 $30.69 8
2021 Q1 1,049,647 $28,455,950 -$2,296,304 $27.13 6
2020 Q4 951,989 $24,503,899 -$937,654 $25.74 5
2020 Q3 829,803 $18,621,000 -$6,344,901 $22.44 4
2020 Q2 889,153 $21,358,000 +$865,610 $24.07 6
2020 Q1 670,823 $13,253,000 +$3,768,963 $19.76 5
2019 Q4 256,841 $6,106,000 +$1,425,786 $23.74 4
2019 Q3 196,992 $3,871,000 +$1,346,247 $19.44 6
2019 Q2 128,470 $2,702,000 +$2,446,941 $20.71 6
2019 Q1 12,149 $252,000 +$252,000 $16.95 3
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .